Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Thomas F Luscher"'
Autor:
Rahim Kanji, Vasileios F Panoulas, Alison Duncan, Simon W Davies, Thomas F Luscher, Saeed S Mirsadraee, Deepa R J Arachchillage, Diana A Gorog
Publikováno v:
Cardiovascular Research. 118
Background Patients with severe aortic stenosis (AS) are at risk of both bleeding and thrombotic events. The high shear and flow rates across the stenotic aortic valve (AV) degrade von Willebrand factor high molecular weight multimers increasing blee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86922f7fc4f8187d14b62f2f65098c49
https://doi.org/10.1093/cvr/cvac157.035
https://doi.org/10.1093/cvr/cvac157.035
Autor:
Shafeeq Ahmed A Mohammed, Mattia Albiero, Samuele Ambrosini, Karsai Gergely, Florian Wenzl, Era Gorica, Vincenzo Calderone, Paolo Madeddu, Gaia Spinetti, Thomas F Luscher, Sarah Costantino, Gian P Fadini, Francesco Paneni
Publikováno v:
Circulation. 144
Introduction: Therapeutic modulation of blood vessel growth is a promising therapeutic strategy for the prevention of limb ischemia in diabetic (DM) patients with peripheral artery disease (PAD). Epigenetic changes, namely posttranslational histone m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d2825e410f78be649363f9d93340ecd
https://doi.org/10.1161/circ.144.suppl_1.10474
https://doi.org/10.1161/circ.144.suppl_1.10474
Autor:
Kimberly Brown, Jonathan Hansen, Thomas F. Luscher, Danielle M. Brennan, Jeffrey Borer, Venu Menon, A M Lincoff, Steven E. Nissen
Publikováno v:
Journal of the American College of Cardiology. 71:A415
Left ventricular hypertrophy (LVH) is an independent risk factor for cardiovascular (CV) mortality. The PRECISION trial evaluated the CV safety of celecoxib and nonselective NSAIDs. We assessed the contemporary impact of LVH on CV outcomes diagnosed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95f821368d782c9d0c65bb92a6eaa183
https://doi.org/10.1016/s0735-1097(18)30956-2
https://doi.org/10.1016/s0735-1097(18)30956-2
Autor:
Mingyuan Shao, A M Lincoff, Kathy Wolski, Grant W. Reed, Mouin Abdallah, Neville Yeomans, Peter Libby, Thomas F. Luscher, Steven E. Nissen, Lisa Wisniewski, Elaine Husni, David Y. Graham, Jeffrey Borer, Venuy Menon, Daniel H. Solomon
Publikováno v:
Journal of the American College of Cardiology. 71:A85
The PRECISION trial demonstrated the non-inferiority of celecoxib to ibuprofen or naproxen for cardiovascular (CV) safety in patients with arthritis. A comparison of the overall safety of each agent stratified by drug dose has yet to be reported. Pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ea84435c62a3f1ba10fd594c76d36a4
https://doi.org/10.1016/s0735-1097(18)30626-0
https://doi.org/10.1016/s0735-1097(18)30626-0
Autor:
Sam J van der Tuin, Susan Kuhnast, José W Van der Hoorn, Jan B van Klinken, Branko Simic, Elsbet J Pieterman, Louis M Havekes, Ulf Landmesser, Thomas F Luscher, Ko Willems-van Dijk, Patrick C Rensen, J W Jukema, Hans M Princen
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 34
Introduction: The residual risk that remains after statin treatment has stimulated the search for secondary treatment targets. Epidemiological studies propose HDL-C as a possible candidate. Cholesteryl ester transfer protein (CETP) transfers choleste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4d745351103b05c2c030450a60effcc
https://doi.org/10.1161/atvb.34.suppl_1.246
https://doi.org/10.1161/atvb.34.suppl_1.246
Autor:
Thomas F, Luscher, Maarten L, Simoons
Publikováno v:
European heart journal. 34(28)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f9c2cb7e0cb4ff6364b9ccca54a074b3
https://pubmed.ncbi.nlm.nih.gov/23872325
https://pubmed.ncbi.nlm.nih.gov/23872325
Autor:
Andreas J. Flammer, Isabella Sudano, Frank Hermann, Steffen Gay, Adrian Forster, Michel Neidhart, Peter Künzler, Frank Enseleit, Daniel Périat, Matthias Hermann, Juerg Nussberger, Thomas F. Luscher, Roberto Corti, Georg Noll, Frank Ruschitzka
Background— The excess in cardiovascular risk in patients with rheumatoid arthritis provides a strong rationale for early therapeutical interventions. In view of the similarities between atherosclerosis and rheumatoid arthritis and the proven benef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d02d57b98949a05f8b834d677e850b94
https://www.zora.uzh.ch/id/eprint/2877/
https://www.zora.uzh.ch/id/eprint/2877/
Autor:
Elena Osto, Christian M Matter, Alexey Kuroedov, Giovanni Camici, Tadeusz Malinski, Markus Bachschmid, Thomas Stallmach, Jan Boren, Sabino Iliceto, Thomas F Luscher, Francesco Cosentino
Publikováno v:
Circulation. 116
Background Hypercholesterolemia-induced endothelial dysfunction (ED) is a major trigger for atherosclerosis. The c-Jun-N-terminal kinases (JNKs) belong to the mitogen-activated protein kinase family. Genetic deletion of JNK2 has been shown to decreas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa4f47f16c454d6d4c104e9b8d0446ec
https://doi.org/10.1161/circ.116.suppl_16.ii_180
https://doi.org/10.1161/circ.116.suppl_16.ii_180
Autor:
Karin, Frischknecht, Helen, Greutert, Christian, Weisshaupt, Mathias, Kaspar, Zhihong, Yang, Thomas F, Luscher, Thierry P, Carrel, Felix C, Tanner
Publikováno v:
Journal of vascular research. 43(4)
The remarkable patency of internal mammary artery (MA) grafts compared to saphenous vein (SV) grafts has been related to different biological properties of the two blood vessels. We examined whether proliferation and apoptosis of vascular smooth musc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::258cf0b0a8c15be91732ed9bc22c3b2c
https://pubmed.ncbi.nlm.nih.gov/16733369
https://pubmed.ncbi.nlm.nih.gov/16733369
Autor:
Mehdi, Namdar, Thomas F, Hany, Pascal, Koepfli, Patrick T, Siegrist, Cyrill, Burger, Christophe A, Wyss, Thomas F, Luscher, Gustav K, von Schulthess, Philipp A, Kaufmann
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 46(6)
An accurate, noninvasive technique for the diagnosis of coronary artery disease (CAD) should provide complementary information on coronary anatomy and pathophysiologic lesion severity. We present, what is to our knowledge, the first clinical evaluati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::428cf97b90d976cb1f95d1ea9f70bafd
https://pubmed.ncbi.nlm.nih.gov/15937297
https://pubmed.ncbi.nlm.nih.gov/15937297